Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
Gilead Sciences manufacture solid oral dose medicines. These products (for the treatment of hepatitis and HIV) are tested, packaged and distributed in the EMEA region. Bulk tablets are shipped to the U.S. to be packaged for the U.S. market.